相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma
Rogier M. Reijmers et al.
FEBS JOURNAL (2013)
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
Kai Neben et al.
BLOOD (2012)
Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease
Mindaugas Andrulis et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Gene Expression Profiling in Multiple Myeloma-Reporting of Entities, Risk, and Targets in Clinical Routine
Tobias Meissner et al.
CLINICAL CANCER RESEARCH (2011)
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
Dirk Hose et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
SULFs in human neoplasia: implication as progression and prognosis factors
Caroline Bret et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling
Martina Willhauck-Fleckenstein et al.
ANGIOGENESIS (2010)
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
Rogier M. Reijmers et al.
BLOOD (2010)
Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance
Bijay Nair et al.
BLOOD (2010)
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
Karene Mahtouk et al.
BMC CANCER (2010)
The MicroArray Quality Control (MAQC)-IIII study of common practices for the development and validation of microarray-based predictive models
Leming Shi et al.
NATURE BIOTECHNOLOGY (2010)
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma
Dirk Hose et al.
BLOOD (2009)
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
Anne Catherine Sprynski et al.
BLOOD (2009)
Induction of angiogenesis by normal and malignant plasma cells
Dirk Hose et al.
BLOOD (2009)
TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3
John D. Shaughnessy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells
Caroline Bret et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
Jerome Moreaux et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma
Jean-Luc Harousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
A. Seckinger et al.
ONCOGENE (2009)
The glycosylphosphatidylinositol anchor: A complex membrane-anchoring structure for proteins
Margot G. Paulick et al.
BIOCHEMISTRY (2008)
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity
Atsushi Irie et al.
BONE (2007)
Deciphering the glycocode: the complexity and analytical challenge of glycomics
Kanoelani T. Pilobello et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karene Mahtouk et al.
BLOOD (2007)
Heparanase enhances syndecan-1 shedding - A novel mechanism for stimulation of tumor growth and metastasis
Yang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Differential surface expression and possible function of 9-O- and 7-O-acetylated GD3 (CD60 b and c) during activation and apoptosis of human tonsillar B and T lymphocytes
Michael Erdmann et al.
GLYCOCONJUGATE JOURNAL (2006)
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K. Mahtouk et al.
ONCOGENE (2006)
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma
Bart Barlogie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Thalidomide and hematopoietic-cell transplantation for multiple myeloma
B Barlogie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics
FW Cremer et al.
GENES CHROMOSOMES & CANCER (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of EGF-family receptors and amphiregulin in multiple myeloma.: Amphiregulin is a growth factor for myeloma cells
K Mahtouk et al.
ONCOGENE (2005)
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
S Wuilleme et al.
LEUKEMIA (2005)
The 'miss rate' for the analysis of gene expression data
J Taylor et al.
BIOSTATISTICS (2005)
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis
R Kannagi et al.
CANCER SCIENCE (2004)
A model-based background adjustment for oligonucleotide expression arrays
ZJ Wu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
A global test for groups of genes: testing association with a clinical outcome
JJ Goeman et al.
BIOINFORMATICS (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Glycan-dependent leukocyte adhesion and recruitment in inflammation
JB Lowe
CURRENT OPINION IN CELL BIOLOGY (2003)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors
ZJ Gu et al.
LEUKEMIA (2000)
分享论文
